Celcuity
Clinical-stage biotechnology company that seeks to extend the lives of cancer patients by pursuing an integrated therapeutic and companion diagnostic strategy.
Launch date
Employees
Market cap
€504m
Enterprise valuation
€335m (Public information from Sep 2024)
Share price
$14.85 CELC
Hamel Illinois (HQ)
Authorizing premium user...